Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Stability studies of binding and functional anti-vaccine antibodies.

Hendriks J, Stals C, Versteilen A, Mommaas B, Verhoeven M, Tirion F, Haak MT, Ribbens W, Bosch M, Trommel M, Kostense S.

Bioanalysis. 2014 May;6(10):1385-93. doi: 10.4155/bio.14.96.

PMID:
24958122
2.

A peptide-based Plasmodium falciparum circumsporozoite assay to test for serum antibody responses to pre-erythrocyte malaria vaccines.

Kostense S, Mommaas B, Hendriks J, Verhoeven M, Ter Haak M, Tirion F, Wiesken E, Pau MG, Radosevic K, Goudsmit J.

Clin Vaccine Immunol. 2011 May;18(5):776-82. doi: 10.1128/CVI.00547-10. Epub 2011 Mar 16.

3.

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

Overwijk WW, de Visser KE, Tirion FH, de Jong LA, Pols TW, van der Velden YU, van den Boorn JG, Keller AM, Buurman WA, Theoret MR, Blom B, Restifo NP, Kruisbeek AM, Kastelein RA, Haanen JB.

J Immunol. 2006 May 1;176(9):5213-22.

4.

The impact of self-tolerance on the polyclonal CD8+ T cell repertoire.

Kessels HW, de Visser KE, Tirion FH, Coccoris M, Kruisbeek AM, Schumacher TN.

J Immunol. 2004 Feb 15;172(4):2324-31.

5.

Can the low-avidity self-specific T cell repertoire be exploited for tumor rejection?

Cordaro TA, de Visser KE, Tirion FH, Schumacher TN, Kruisbeek AM.

J Immunol. 2002 Jan 15;168(2):651-60.

6.

Low-avidity self-specific T cells display a pronounced expansion defect that can be overcome by altered peptide ligands.

de Visser KE, Cordaro TA, Kessels HW, Tirion FH, Schumacher TN, Kruisbeek AM.

J Immunol. 2001 Oct 1;167(7):3818-28.

7.

In situ detection of virus- and tumor-specific T-cell immunity.

Haanen JB, van Oijen MG, Tirion F, Oomen LC, Kruisbeek AM, Vyth-Dreese FA, Schumacher TN.

Nat Med. 2000 Sep;6(9):1056-60. No abstract available.

PMID:
10973329
8.

Tumor size at the time of adoptive transfer determines whether tumor rejection occurs.

Cordaro TA, de Visser KE, Tirion FH, Graus YM, Haanen JB, Kioussis D, Kruisbeek AM.

Eur J Immunol. 2000 May;30(5):1297-307.

9.

Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39.

Wolvers DA, Coenen-de Roo CJ, Mebius RE, van der Cammen MJ, Tirion F, Miltenburg AM, Kraal G.

J Immunol. 1999 Feb 15;162(4):1994-8.

Supplemental Content

Loading ...
Support Center